Korean J Nephrol.
2010 Nov;29(6):834-838.
Delayed Recovery of Sedation by Continuous Midazolam Infusion in an ESRD Patient on Peritoneal Dialysis: A Case Report
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea. nephjo.kuh.ac.kr
Abstract
- Midazolam, a benzodiazepine derivatives, is widely used in intensive care unit for sedation of patients who require mechanical ventilation. Although midazolam has a short acting time, it might cause a prolonged sedation, especially in patients with renal failure. We report the case of a 76-year-old man who received peritoneal dialysis and showed prolonged sedation after stopping continuous infusion of midazolam. The patient who has received maintenance hemodialysis for five months admitted in intensive care unit to manage pneumonia and severe congestive heart failure. In ICU, hemodialysis was transferred to peritoneal dialysis due to severe cardiac dysfunction. He was treated with mechanical ventilation under sedation with midazolam. However, even though stopping midazolam, deep sedation by midazolam was not restored. The patient completely recovered from sedation after 280 hours.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Effects of Midazolam and Propofol by Continuous Intravenous Infusion to provide Sedation in Patients who receive Spinal Anesthesia
- Delayed Recovery after Continuous Infusion of Midazolam in Hepatic Dysfunction: A case report
- Continuous Infusion of Midazolam for Short-term Sedation in Critically III Patients
- Sedation with Continuous Infusion of Midazolam for Ventilated Patient in Intensive Care Unit
- A Case Report of Mycobacterium abscessus Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis
